Education

• MD, Cornell University Medical College, 1997
• Surgery Residency, University of Chicago Hospitals, Chicago, IL, 1997-2005
• Research Fellowship, Transplantation Biology Research Center, Massachusetts General Hospital, Boston, MA
• Transplantation Fellowship, University of Wisconsin Hospital and Clinics, Madison, WI, 2005-2007

Clinical Specialties

Dr. Mezrich is certified by the American Board of Surgery. He specializes in solid organ transplant (liver, kidney, and pancreas).

Dr. Mezrich provides a wide range of services including "Scarless" Single-Port Laparoscopic Donor Nephrectomy, Kidney Transplant, Laparoscopic Donor Nephrectomy, Liver Resection, Liver Transplant, and Wedge Resection of the Liver.

Research Interests

Dr. Mezrich’s research interest is in transplant tolerance and how environmental exposures alter the immune system.

Recent Publications

• The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation.
  Van Voorhis M, Fechner JH, Zhang X, Mezrich JD
  Transplantation 2013 Apr 27; 95(8):983-90.
  [PubMed ID: 23263608]
  More Information
• Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.
  Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, Bellingham JM, Odorico JS, Mezrich JD, Pirsch JD, D'Alessandro TM, Vidyasagar V, Hofmann RM, Torrealba JR, Kaufman DB, Foley DP
  Kidney Int. 2013 Jun; 83(6):1185-92.
  [PubMed ID: 23447068]
  More Information
• Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up.
  LaMattina JC, Mezrich JD, Fernandez LA, D'Alessandro AM, Djamali A, Musat AI, Pirsch JD, Foley DP
  Clin Transplant 2013 Mar-Apr; 27(2):193-202.
  [PubMed ID: 23294013, PMC ID: 3622762]
  More Information
• SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.
  Mezrich JD, Nguyen LP, Kennedy G, Nukaya M, Fechner JH, Zhang X, Xing Y, Bradfield CA
  PLoS ONE 2012; 7(9):e44547.
  [PubMed ID: 22970246, PMC ID: 3435281]
  More Information
• The Aryl Hydrocarbon Receptor Influences Transplant Outcomes in Response to Environmental Signals.
  Pauly SK, Fechner JH, Zhang X, Torrealba J, Bradfield CA, Mezrich JD
  Toxicol Environ Chem 2012; 94(6):1175-1187.
  [PubMed ID: 23002321, PMC ID: 3445427]
  More Information